SHANGHAI and NANJING, China and SAN FRANCISCO, March 1, 2022 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products announced that the company's...
News Ticker
- [ January 30, 2023 ] Scientist: Protein Purification – Celltheon – Union City, CA San Francisco Biotech Jobs
- [ January 30, 2023 ] AI predicts global warming will exceed 1.5 degrees in 2030s News
- [ January 30, 2023 ] Oracle executive Troy Tazbaz named new FDA director of digital health News
- [ January 30, 2023 ] Paradigm Announces Acquisition of Welvie News
- [ January 30, 2023 ] Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care News
Copyright © 2022 Biotech Networks, LLC
